Navigation Links
First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes

ard-looking statement can be guaranteed. Among other risks, there can be no guarantee that the development of the products described in this release will be successful, that the products described in this release will receive regulatory approval, or that if approved, will be commercially successful. Forward-looking statements in the press release should be evaluated together with the many uncertainties that affect Bristol- Myers Squibb's business, particularly those identified in the cautionary factors discussion in Bristol-Myers Squibb's Annual Report on Form 10-K for the year ended December 31, 2006, its Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Bristol-Myers Squibb undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.

In the United States, AstraZeneca is a $12.44 billion healthcare business with more than 12,000 employees. For nearly three decades, AstraZeneca has offered drug assistance programs side by side with its medicines, and over the past five years, has provided over $3 billion in savings to more than 1 million patients throughout the US and Puerto Rico. AstraZeneca has been named one of the "100 Best Companies for Working Mothers" by Working Mother magazine and is the only large pharmaceutical company named to FORTUNE magazine's 2007 list of "100 Best Companies to Work For." In 2006, for the fif
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
8. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
9. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
10. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
11. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
Post Your Comments:
(Date:7/29/2015)... -- The Judicial Panel on Multidistrict Litigation (JPML) will ... Inferior vena cava (IVC) Filter lawsuits filed against C.R. ... already been centralized by the JPML. "IVC ... for a pulmonary embolism. The filters are designed to ... against Bard and Cook involve incidents of retrievable IVC ...
(Date:7/29/2015)... Mass. , July 29, 2015 ... an investor presentation August 6, 2015 at 10:45 ... Robert Clarke , Chief Executive Officer, will review ... the Company,s pipeline of inhaled therapeutics based on ... Date:     Thursday, August 6, 2015 Time:    ...
(Date:7/29/2015)... 29, 2015  Fifty groups representing 500,000 patients, doctors, ... to launch the AllTrials campaign in the US. The ... and future, to be registered and the results from ... Ben Goldacre explains: "Patients want the treatments that ... on what works. Unfortunately, we now know that around ...
Breaking Medicine Technology:IVC filter litigation continues; law firm provides free information to IVC filter patients 2Pulmatrix to Webcast Investor Presentation and Provide Update on Pipeline of Inhaled Therapeutics August 6th 2Fixing Your Medicine: AllTrials Campaign Launches in US 2Fixing Your Medicine: AllTrials Campaign Launches in US 3
... Ga., Sept. 28, 2011 Kimberly-Clark Health Care (KCHC) ... the Food and Drug Administration (FDA) to market the ... that the FDA has granted any manufacturer 510(k) clearance ... with the designation of a Class II medical device. ...
... Visionsense Corp announces an unique milestone this week when ... procedure with the VSii system. Dr. ... of Neurosurgery at Emory University and Professor of Neurosurgery ... pituitary adenoma in the morning of September 22nd, 2011 ...
Cached Medicine Technology:Kimberly-Clark Health Care Receives Landmark FDA Clearance for Pediatric Face Mask 2
(Date:7/29/2015)... ... July 29, 2015 , ... Topical BioMedics, Inc., announces ... Relief and Healing Cream designated as the nonprofit’s natural pain reliever of choice.     ... Line of Duty Deaths (LODD) and the high rate of pain and injuries ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to the Miami ... or alcohol addiction and mental health disorders. Acu-detox may begin taking off in the ... from drug and alcohol addiction. Although acupuncture is not a new practice, it is ...
(Date:7/29/2015)... ... July 29, 2015 , ... For the second year ... featured in the list of the 50 fastest growing companies in Jacksonville. This annual ... business community. On July 16th, a team of Vast Bridges staffers were on hand ...
(Date:7/29/2015)... ... July 29, 2015 , ... Fastline Publications, Inc., will ... on RFD-TV. , Fastline is dedicated to quality agricultural advertising, both in print ... largest and freshest searchable agriculture equipment database in the world. The site has ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Employee Fiduciary, ... will include the general contact information, website, types of plans administered, years in business, ... business listing and have at least one plan with Employee Fiduciary. A search can ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Vast Bridges Continues Its Swift Growth 2Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2Health News:Employee Fiduciary Launches Financial Advisor Directory 2
... psychological tests on its recruits in a bid to control ... in the past few years, a defence scientist said Friday. ... October), we would be able to gauge the personality of ... the ratio of positive to negative traits," Manas Kumar Mandal, ...
... recently launched Chest Pain Clinics in the city would make ... ,The hospital launched a number of Chest Pain Clinics ... loss of time in order to save lives. ... 'The first few hours after the heart attack is the ...
... reactions to newer iodine-containing contrast agents (nonionic contrast media), ... study conducted by researchers from the University of Michigan ... Ann Arbor. ,'A major, if not the ... types of reactions. Such reactions can be mild; for ...
... why overweight elderly adults have low levels of vitamin D ... USDA Human Nutrition Research Center on Aging at Tufts University ... not account for low levels of vitamin D in elders ... high percent body fat have lower levels of 25-hydroxyvitamin D, ...
... muscle that separates the chest cavity from the abdominal ... birth defect known as congenital diaphragmatic hernia (CDH), results ... allows abdominal organs to migrate into the chest cavity. ... CDH, and in fact is the major predictor of ...
... are heaving a sigh of relief. The much-awaited double lung ... ,The 50-year-old man, as yet unnamed, is stable at the ... say confidently he has come through safely. ,It ... surgeons that is. A team at University of Michigan Health ...
Cached Medicine News:Health News:Army to Conduct Psychological Tests During Recruits to Curb Suicides 2Health News:Newer Contrast Agents Safe for Children 2Health News:Lack of Sun Does Not Explain Low Vitamin D in Elderly Who are Overweight 2Health News:Understanding and Treating Congenital Diaphragmatic Hernia 2Health News:Understanding and Treating Congenital Diaphragmatic Hernia 3Health News:Understanding and Treating Congenital Diaphragmatic Hernia 4Health News:Double Lung Transplant Man in Michigan Recovering 2
... Splints provide finger stability and control motion ... and loss of control due to stroke ... from translucent, neutral-tone plastic with broad bands ... design makes them the most versatile ring ...
... duty, controlled stretch knee support that helps ... full range of motion. The medial ... knee, and help to keep the elastic ... This is an excellent support for post-surgical ...
... to breathable foam. Three piece design for ... with loop closures. Lightweight rigid posterior stays ... ,Available with optional hot and cold therapy ... the pain cycle by providing cold therapy ...
... the outstanding features of our Neomax Premium ... Technology. , This manufacturing process allows us ... the bunching and irritation in the popliteal ... , ,Colors available: Blue, Black. ...
Medicine Products: